Shanghai Labway Clinical Laboratory Co Ltd (301060) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Labway Clinical Laboratory Co Ltd (301060) has a cash flow conversion efficiency ratio of 0.081x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥135.78 Million ≈ $19.87 Million USD) by net assets (CN¥1.67 Billion ≈ $244.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 301060 net asset quality score to measure how much of total assets are equity-financed.
Shanghai Labway Clinical Laboratory Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Shanghai Labway Clinical Laboratory Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 301060 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Shanghai Labway Clinical Laboratory Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Labway Clinical Laboratory Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Brilliance Technology Co Ltd
SHE:300542
|
-0.164x |
|
Avax S.A
AT:AVAX
|
0.076x |
|
Shanghai Rongtai Health Tech
SHG:603579
|
-0.006x |
|
JinJian Cereals Industry Co Ltd
SHG:600127
|
0.039x |
|
Sinostar Cable Co. Ltd.
SHE:300933
|
0.000x |
|
IntelliEPI Cayman
TWO:4971
|
0.031x |
|
Continental Holdings Corp
TW:3703
|
0.160x |
|
Viyash Scientific Limited
NSE:SEQUENT
|
0.051x |
Annual Cash Flow Conversion Efficiency for Shanghai Labway Clinical Laboratory Co Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see 301060 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.64 Billion ≈ $240.69 Million |
CN¥268.85 Million ≈ $39.34 Million |
0.163x | +37.55% |
| 2024-12-31 | CN¥1.82 Billion ≈ $266.37 Million |
CN¥216.31 Million ≈ $31.65 Million |
0.119x | -56.98% |
| 2023-12-31 | CN¥1.98 Billion ≈ $289.76 Million |
CN¥546.99 Million ≈ $80.04 Million |
0.276x | +645.91% |
| 2022-12-31 | CN¥2.27 Billion ≈ $332.58 Million |
CN¥84.17 Million ≈ $12.32 Million |
0.037x | -72.83% |
| 2021-12-31 | CN¥1.64 Billion ≈ $239.96 Million |
CN¥223.51 Million ≈ $32.71 Million |
0.136x | +1.28% |
| 2020-12-31 | CN¥1.25 Billion ≈ $182.53 Million |
CN¥167.87 Million ≈ $24.57 Million |
0.135x | +131.24% |
| 2019-12-31 | CN¥1.21 Billion ≈ $177.52 Million |
CN¥70.60 Million ≈ $10.33 Million |
0.058x | -62.80% |
| 2018-12-31 | CN¥1.18 Billion ≈ $172.83 Million |
CN¥184.79 Million ≈ $27.04 Million |
0.156x | +280.90% |
| 2017-12-31 | CN¥1.10 Billion ≈ $161.60 Million |
CN¥-95.52 Million ≈ $-13.98 Million |
-0.086x | -295.93% |
| 2016-12-31 | CN¥614.70 Million ≈ $89.95 Million |
CN¥27.14 Million ≈ $3.97 Million |
0.044x | -83.09% |
| 2015-12-31 | CN¥305.25 Million ≈ $44.67 Million |
CN¥79.70 Million ≈ $11.66 Million |
0.261x | +163.44% |
| 2014-12-31 | CN¥201.13 Million ≈ $29.43 Million |
CN¥-82.77 Million ≈ $-12.11 Million |
-0.412x | -3402.03% |
| 2013-12-31 | CN¥130.79 Million ≈ $19.14 Million |
CN¥1.63 Million ≈ $238.52K |
0.012x | -- |
About Shanghai Labway Clinical Laboratory Co Ltd
Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, precision medicine, CRO, and sample bank laboratory services; scientific research technology and testing… Read more